The second edition of the MOH clinical practice guidelines on hypertension for Singapore was published in 2005. Since then, more facts about this important condition have emerged, particularly those recommending home blood pressure monitoring (HBPM) and 24-hour ambulatory blood pressure monitoring (ABPM) as key procedures in diagnosing suspected hypertension.
How to use this document
All recommendations made in the CPG are summarised in this document. Please note the following: (a) Each recommendation has a corresponding Grade of Recommendation and Level of Evidence (refer to Appendix for details). (b) The details/ explanations of each recommendation can be found in the full CPG document using the page numbers provided. Key recommendations are highlighted in grey.
Commonly used abbreviations
The following is a list of abbreviations commonly used in this set of guidelines (arranged in alphabetical order) and a description of what they represent. Definitions are given in Table 1 for subjects who are not on antihypertensive medication and not acutely ill. As BP is characterised by large spontaneous variations, the diagnosis of hypertension should be based on multiple BP measurements taken on several separate occasions.

How should BP be measured?
For clinic or office BP measurement, BP is measured at rest several times on several occasions, with the patient in a supine or sitting position.
D
Use the following procedures when recording BP: 1. Allow the patient to sit or lie down for at least three minutes before measuring the BP. 2. The patient should refrain from smoking or taking caffeinated drinks during the 30 minutes before measurement. 3. Use a cuff with a bladder 12-13 cm × 35 cm in size.
A cuff with a larger bladder should be used for large upper arms, while a thigh cuff should be used for extremely large arms. 4. When using the auscultatory method, use the disappearance of phase V Korotkoff sounds to measure the diastolic BP. 5. Measure the BP in both arms at the first visit; subsequently re-measure BP on the arm with the higher reading, if applicable. 6. Take two or more readings separated by two minutes.
Average these two values. If the first two readings differ by 5 mmHg or more, further readings should be obtained and averaged. 7. In elderly subjects and diabetic patients, measure the BP in the supine (or sitting) position and within two minutes after standing, to record any postural fall in BP. 8. Place the manometer cuff at the level of the heart, regardless of the position of the patient. The definitions of hypertension based on HBPM and ABPM are listed in Table 2 . The identifiable secondary causes of hypertension are listed in Table 3 below. 
Choice of antihypertensive drugs
The choice of antihypertensive drug should be tailored to the individual patient, taking into account the following factors, in addition to risk profile and cost: (1) side effects; (2) drug-drug interactions; and (3) patient preference. Begin first-line antihypertensive treatment with any one, or an appropriate combination, of the five major drug classes available in Singapore, namely: (1) angiotensinconverting enzyme inhibitor (ACE inhibitor); (2) angiotensin II receptor blocker (ARB); (3) calcium-channel blocker (CCB); (4) diuretic (thiazide, thiazide-like, or loop); and (5) betablocker.
Other classes of antihypertensive drugs, such as methyldopa, hydralazine and alpha-adrenergic receptor blockers (peripheral alpha-1 blockers, e.g. terazosin; central alpha-2 blockers, e.g. clonidine), may be used in combination treatment as third or fourth-line agents.
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Follow-up
Follow-up during evaluation and stabilisation of treatment should be sufficiently frequent to monitor the BP and other cardiovascular risk factors (Table 6 ).
D
Patients with the following problems should be referred to a hypertension specialist or clinic: (1) Conditions needing emergency or urgent treatment, e.g. malignant hypertension, hypertensive heart failure, or other impending complications. (2) Hypertension that is difficult to manage, e.g. unusually labile BP, or hypertension refractory to multiple drugs in different pharmacological classes. (3) Secondary hypertension, i.e. hypertension due to an underlying cause, such *If two conditions exist in the same patient, the condition that is mentioned first will determine the blood pressure level. †Blood pressure control should be optimised for individual patients to achieve the blood pressure targets without worsening the eGFR and cardiovascular outcomes. Home blood pressure target will be the lower of either 135/85 mmHg, or the clinic target as determined above. The objective of managing hypertension is ultimately to decrease the patients' overall risks of morbidity and mortality. The greater the total cardiovascular disease risk, the more rigorously the BP should be controlled.
Treating high blood pressure in special conditions
However, the BP level attainable with antihypertensive treatment is influenced by medication side effects and other comorbidities, such as diabetes mellitus, chronic kidney disease, CAD and cerebrovascular disease. Good clinical judgement should therefore be exercised in every patient.
The schedules shown in Table 6 are recommended to allow patients and healthcare providers to optimise the quality of care. Recommended best practice based on the clinical experience of the guideline development group.
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